Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Investing News Network

20:49 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Investing News Network" found in our extensive news archives from over 250 global news sources.

More Information about Investing News Network on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Investing News Network for you to read. Along with our medical data and news we also list Investing News Network Clinical Trials, which are updated daily. BioPortfolio also has a large database of Investing News Network Companies for you to search.

Showing News Articles 1–25 of 1,300+ from Investing News Network

Friday 15th February 2019

Life Science Big News Roundup: Isodiol Acquires CBD Naturals® Consumer Brands; MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement

In case you missed it, here is this week’s life science big news roundup. The post Life Science Big News Roundup: Isodiol Acquires CBD Naturals® Consumer Brands; MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement appeared first on Investing News Network.

Hoth Therapeutics Announces Pricing of Initial Public Offering and Trading on the Nasdaq

Hoth Therapeutics (NASDAQ:HOTH) has announced the pricing of its initial public offering of 1,250,000 shares of its common stock at an initial offering price to the public of $5.60 per share. As quoted in the press release:  All shares of common stock are being offered by Hoth. In addition, Hoth has granted the underwriters a 30-day option … Continued The post Hoth Therapeutics Announces ...

Thursday 14th February 2019

Medtronic Subsidiary Wins Health Canada License for HVAD System

This is the first heart pump that received a license from Health Canada for less-invasive implant procedures The post Medtronic Subsidiary Wins Health Canada License for HVAD System appeared first on Investing News Network.

Isodiol International Inc. Acquires CBD Naturals® Consumer Brands, Expands Consumer Package Goods Portfolio and Receives Strategic Funding to Expand U.S. Retail Footprint

The transaction includes over 15 brands, 40 brand domain names, 50 proprietary ingredient and product formulas, over 100,000 units of inventory, numerous pre-existing distribution relationships, and a comprehensive distribution and marketing strategy The post Isodiol International Inc. Acquires CBD Naturals® Consumer Brands, Expands Consumer Package Goods Portfolio and Receives Strategic Funding ...

Green Growth Brands Launches Seventh Sense eCommerce Website

Green Growth Brands Inc. (CSE:GGB OTCQB: GGBXF)(GGB or the Company) is pleased to announce the launch of ShopSeventhSense.com. The post Green Growth Brands Launches Seventh Sense eCommerce Website appeared first on Investing News Network.

Biocure Technology Inc. Announces Private Placement

Biocure Technology Inc. (CSE:CURE, OTCQB:BICTF) ("CURE" or the "Company") is pleased to announce that it has arranged a non-brokered private placement of 6,976,745 million units at 43 cents per unit for gross proceeds of $3 Million or more, depending on investor interest. The post Biocure Technology Inc. Announces Private Placement appeared first on Investing News Network.

Isodiol International Inc. Appoints Beverage Industry Veteran, Kevin Swadish, to a Newly Created Position as Chief Revenue Officer

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”) announces the appointment of beverage industry executive Kevin Swadish to the newly created C-level position of Chief Revenue Officer of Isodiol.  The post Isodiol International Inc. Appoints Beverage Industry Veteran, Kevin Swadish, to a Newly Created Position as Chief Revenue Officer appear...

Naturally Splendid to Acquire Cannabinoid Extraction Equipment from Wahupta

NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSXV:NSP)(OTCQB: NSPDF)(FRANKFURT:50N) is pleased to announce that it proposes to acquire certain cannabinoid extraction equipment with a value of $1,025,000 CDN, (the “Extraction Equipment”) from Wahupta Ventures Inc. (“Wahupta”) by issuing a total of 5,540,541 common shares of Naturally Splendid.   The post N...

Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference

Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “Company” or “Nash Pharma”) is pleased to announce that it has been accepted to present its pre-clinical data on its inflammatory bowel disease (“IBD”) research program for both Colitis and Crohn’s disease at the upcoming Digestive Diseas...

Wednesday 13th February 2019

PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical") is pleased to announce the appointment of Dr. Makarand (Mak) Jawadekar as the President of the Company, effective immediately. The post PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President appeared first on Investing News Network.

Green Growth Brands Opens First CBD Shop in Kentucky Mall

Green Growth Brands Inc. (CSE:GGB OTCQB: GGBXF) (GGB or the Company) is pleased to announce the opening of its first Seventh Sense CBD Shop at the Fayette Mall in Lexington, Kentucky. The post Green Growth Brands Opens First CBD Shop in Kentucky Mall appeared first on Investing News Network.

Tuesday 12th February 2019

FDA Blasts McKesson for Shipping Illegal Opioid Products

According to a statement from the FDA, McKesson failed to identify, isolate or investigate "illegitimate medications" it shipped. The post FDA Blasts McKesson for Shipping Illegal Opioid Products appeared first on Investing News Network.

Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan

Conatus Pharmaceuticals (NASDAQ:CNAT) has announced it has finished enrollment of ENCORE-LF, a phase 2b clinical trial. As quoted in the press release: “With screening in the ENCORE-LF clinical trial complete, we remain on track for clinical events as announced last quarter, with top-line results expected in mid-2019,” said David T. Hagerty, M.D., Executive Vice President … Continued The...

Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings

Fortress Biotech (NASDAQ: FBIO) has announced it completed the second and final stage of the previously-announced sale of its remaining holdings of National Holdings. As quoted in the press release: Pursuant to the terms of the stock purchase agreement dated November 14, 2018 (the “Purchase Agreement”).  B. Riley, along with two other minority purchaser designees, collectively purchased ...

Isodiol International Inc. Sharpens Strategy for Growth, Profitability, and Increases in Shareholder Value

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F)(the “Company” or “Isodiol”), announces plans to refocus its business strategy on core competencies and key market segments. The post Isodiol International Inc. Sharpens Strategy for Growth, Profitability, and Increases in Shareholder Value appeared first on Investing News Network.

Nemaura Reports Third Quarter 2018 Financial Results

Nemaura Medical (NASDAQ:NMRD) has announced its financial results for Q3 ended December 30, 2018. As quoted in the press release: Recent Highlights and Accomplishments: •           Nemaura Signed License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar •           Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submissio...

Cannara: A Vertically-Integrated Cannabis Company in the Making; Leveraging Quebec’s Market

Cannara Biotech Inc. (CSE:LOVE), a cannabis company based in Quebec, has launched its campaign on the Investing News Network’s Cannabis channel. The post Cannara: A Vertically-Integrated Cannabis Company in the Making; Leveraging Quebec’s Market appeared first on Investing News Network.

PreveCeutical Announces Closing of Non-Brokered Private Placement

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)  (the "Company" or "PreveCeutical") announces the closing of a non-brokered private placement financing (the "Financing"). The post PreveCeutical Announces Closing of Non-Brokered Private Placement appeared first on Investing News Network.

BriaCell Appoints Jamieson Bondarenko to its Board of Directors

BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF)("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces the appointment of Jamieson Bondarenko to the Company's Board of Directors. The post BriaCell Appoints Jamieson Bondarenko to its Board of Directors appeared first on Investing News Network.

Monday 11th February 2019

Cognetivity Advancing AI Platform to Detect Mental Health Disorders

Sina Habibi, CEO of Cognetivity Neurosciences, spoke with INN about the company’s partnership with DPUK and additional plans for 2019. The post Cognetivity Advancing AI Platform to Detect Mental Health Disorders appeared first on Investing News Network.

Cognetivity Advancing AI Platform to Treat Mental Health Disorders

Sina Habibi, CEO of Cognetivity Neurosciences, spoke with INN about the company’s partnership with DPUK and additional plans for 2019. The post Cognetivity Advancing AI Platform to Treat Mental Health Disorders appeared first on Investing News Network.

Novus Doses First Patient in Phase 1 Pharmacodynamics Study

The pharmacodynamics phase 1 clinical trial began in February and is expected to be completed sometime in March. The post Novus Doses First Patient in Phase 1 Pharmacodynamics Study appeared first on Investing News Network.

Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100

Aduro Biotech (NASAQ:ADRO) has announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 for the treatment of refractory . melanoma. As quoted in the press release: The multicenter trial (see www.clinicaltrials.gov, identifier: NCT02675439), which is part of an ongoing research and development collaboration with Novartis, will enroll advanced melanoma … Continued The pos...

Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022

Adverum Biotechnologies (NASDAQ:ADVM) has announced non-human private (NHP) long-term safety data of ADVM-022,  gene therapy currently in phase 1 to treat wet age-related macular degeneration (wet AMD). As quoted in the press release: Data was presented by David M. Brown, M.D., Clinical Professor of Ophthalmology at Baylor College of Medicine, vice-chair for research at the … Continued The ...

Green Growth Brands Partners with Simon Property Group to Launch America’s First Chain of CBD Shops

Green Grown Brands (CSE:GGB) (OTCQB: GGBXF) ("GGB" or "the Company") today announced that it has entered into an agreement through which the Company will gain access to 108 prime shop locations in U.S. malls owned and operated by the Simon Property Group, Inc. (NYSE: SPG) ("Simon"). The post Green Growth Brands Partners with Simon Property Group to Launch America’s First Chain of CBD Shops...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks